Conference Information

Welcome Message

Dear Esteemed Participants,

We are delighted to welcome you to the 3^rd International Conference on Cancer Research and Treatment, taking place on October 17-18, 2024, in London, UK.

This year's Cancer 2024 conference represents a crucial juncture in our collective quest for advancements in cancer research and therapy. Over the next two days, we will come together to explore ground breaking research, share innovative treatment methods, and discuss the latest developments in oncology. This event unites a distinguished assembly of experts from around the globe, all committed to pushing the boundaries of cancer care and improving patient outcomes.

London, with its vibrant blend of contemporary life and rich cultural heritage, provides a fitting backdrop for our discussions. The city's iconic landmarks and diverse cultural landscape offer a unique environment for expanding our knowledge, forming new partnerships, and envisioning the future of cancer treatment.

We encourage you to immerse yourself in the sessions that align with your interests and expertise. Take advantage of the opportunity to engage with fellow participants, exchange pioneering ideas, and explore new avenues that could transform the field of cancer research and treatment.

Once again, welcome to the 3rd International Conference on Cancer Research and Treatment. We hope your experience here will be both enriching and inspiring.

Best regards,
Marina jenny,
Program Manager
Organizing Committee | Cancer 2024
Email: cancer@pulsusgather.com
Whatsapp: +44 7389644903

Deadlines

Dates to be highlighted for Cancer 2024 Conference

Deadline for 3^rd Phase Abstract Submission: October 10, 2024.
Deadline for Final Paper Submission: October 10, 2024.
Deadline for 2^ndPhase Early Bird Registration: September 30, 2024.
Notification of Abstract Acceptance or Rejection: Within 2-3 days.
Conference Dates: October 17-18,2024
*By Midnight-11:59 pm

Together, advance your understanding of cancer! Take advantage of our amazing discounts on group registration for the Cancer 2024. Assemble your Co-workers! Get a 25% discount off the total registration charge when you register a group of five or more people.

But there's still more! Check the Cancer 2024 website for details on how to register early and receive exclusive early bird benefits.

Your team and I can save a tonne of money on this premier cancer research and treatment conference by enrolling as a group and taking advantage of early bird discounts. Don't pass up this chance to grow professionally, network, and learn new things!

Venue

Enjoy a Comfortable Stay at Cancer 2024 with Our Convenient Accommodation Options

Ensure a seamless and enjoyable experience during Cancer 2024 with our tailored accommodation options, designed for both comfort and productivity.

Optimize Your Visit: Take advantage of our flexible check-in and check-out options (subject to room availability) to make the most of your time in London.

Room Options:

Single Occupancy: Choose a single room for a peaceful and private stay.
Double Occupancy: Opt for a double room if you'd like to share the experience with a colleague.

Need Assistance?

For additional room bookings or if you need separate arrangements for colleagues or family, please contact our dedicated team at cancer@pulsus.gather.com . Provide us with your preferred package details and the number of nights you need, and we'll assist you promptly. A personalized registration link will be sent to facilitate a smooth booking process.

Confirm Your Stay: To secure your reservation for the desired dates, please make a prompt payment of the applicable fee. You will receive a confirmation email upon payment to ensure your booking is confirmed.

Explore Your Venue: Discover the exciting location and amenities available at the Cancer 2024 Venue Page.

Our team is ready to help with any questions or booking needs you may have. Please contact us at cancer@pulsusgather.com for support.

Abstract Guidelines

Abstract Acceptance Criteria

Are you conducting research that could transform the field of cancer treatment? The Cancer 2024 invites you to submit your abstracts for papers and posters. Share your insights and connect with a global community dedicated to advancing cancer care.

Your submission will be evaluated according to these criteria:

Thematic Relevance: Does your research align with the conference's central themes, such as innovative treatments or rehabilitation strategies? For detailed themes, please visit our Cancer 2024 website.
Clarity and Structure: Is your abstract clearly organized, succinct, and able to effectively communicate the essence of your research?
Methodological Rigor (for Research Studies): Does your abstract detail a solid research design, including clear research questions, data collection methods, analysis plans, and anticipated results?
Clinical Impact: Does your topic have relevance to enhancing clinical practice and improving patient outcomes in cancer care?
Integration of Research and Practice: Does your research bridge theoretical concepts with practical applications, providing valuable insights for both clinicians and patients?
Originality and Innovation: Does your abstract offer new perspectives or novel approaches that could make a significant impact in the field of cancer?

Meeting these criteria will strengthen your chances of being selected for presentation. We welcome submissions that ignite new discussions and contribute to the progress of cancer health.

Reviewing Process

Cancer 2024 ensures a transparent and efficient review process adhering to international standards. We utilize the expertise of a global network of cancer specialists to conduct thorough and impartial evaluations.

Key Features:

Prompt Feedback: Receive review results within 48 hours of submission, enabling you to swiftly plan your next steps.
Double-Blind Review: Benefit from anonymous evaluations by at least two qualified cancer experts to minimize bias and focus on the scientific quality of your work.
Constructive Feedback: Acceptance or rejection notifications will include valuable feedback from reviewers to help improve your manuscript or poster.
Streamlined Revisions: If revisions are necessary, feedback will be provided within 24 hours. We consider extension requests on a case-by-case basis if revisions are complex.
Final Decision: The final decision on abstracts will be made by the Cancer 2024 Scientific Committee Chair, ensuring a thorough and balanced review.

Submission Guidelines

Ensure a smooth submission process and share your research with the global cancer community at Cancer 2024! Follow these steps to submit your abstract:

Submission Platform:

Submit your abstract electronically in Word format through our online submission system at Cancer 2024 website.
Choose the appropriate presentation category: Oral, Poster, or Young Investigator Award (if applicable).

Content and Structure:

Session Selection: Select the most relevant session from the Scientific Sessions list for your research.
Reference Format: Use the provided reference template for consistent citations.
Word Limit: Ensure your abstract is both concise and informative, adhering to a maximum length of 300 words..
Relevance: Ensure your abstract aligns with the conference's themes/topics.
Author Information: Clearly state the affiliation and institution for each author involved.
Abstract Structure: Organize your abstract with the following sections:
- Abstract
- Introduction
- Methods
- Results
- Discussion
- Conclusions
- Acknowledgements (if applicable)
- References
Author Biography: Include a brief biography (maximum 150 words) for each author, along with a photograph and email address. Refer to the Abstract Template here for additional guidance.

Contact Us:

We are here to assist you! For any questions or clarifications regarding the abstract submission process, please contact us at cancer@pulsusgather.com. Our goal is to deliver quick and useful responses.

Scientific Sessions

Session 1: Cancer Biology

Throughout our lifetimes, our cells are genetically programmed to carry out a multitude of functions. Weary cells that die in a regular cycle must be replaced with new ones. A tumour, sometimes known as a "swelling," is the outcome of an uncontrollably expanding cell caused by faulty DNA. However, in the context of cancer, the phrase refers to abnormal tissue growth.

Track 1-1 Genetic Mutations and Cancer
Track 1-2 Tumour Microenvironment
Track 1-3 Oncogenes and Tumour Suppressor Genes
Track 1-4 Cell Signalling Pathways
Track 1-5 Cancer Stem Cells

Related Conferences:

Related Associations:

American Association for Cancer Research (AACR) |American Society of Clinical Oncology (ASCO) |European Society for Medical Oncology (ESMO) |International Cancer Research Organization (ICRO) |American Society for Radiation Oncology (ASTRO) |American Association of Cancer Education (AACE) |European Association for Cancer Research and Treatment (EACR) |Society for Immunotherapy of Cancer (SITC) |National Comprehensive Cancer Network (NCCN) |Global Society of Oncology Pharmacy Practitioners (GSOPP) |Canadian Association of Provincial Cancer Agencies (CAPCA) |Asian Pacific Organization for Cancer Prevention (APOCP)

Related Journals:

Session 2: Early Detection and Diagnosis

Finding and diagnosing cancer early on allows for treatment of the illness while it is still in its most manageable phases. In this method, sophisticated imaging technologies like MRI and CT scans are used in addition to screening tests including Pap smears, colonoscopies, and mammograms. Furthermore, new methods like genetic testing and liquid biopsies are improving the capacity to identify cancer earlier and with greater accuracy.

Track 2-1 Screening Technique
Track 2-2 Biomarkers in Early Detection
Track 2-3 Imaging Technologies
Track 2-4 Liquid Biopsies
Track 2-5 Genetic Testing and Personalized Diagnosis

Related Conferences:

Related Associations:

Related Journals:

Session 3: Therapeutic Strategies

Cancer therapeutic techniques include a variety of treatments intended to specifically target and eradicate cancer cells. These include radiation treatment, which utilizes high-energy radiation to eliminate tumours, chemotherapy, which uses chemicals to kill or inhibit cancer cells, and targeted therapies, which target cancer cells directly based on their molecular or genetic makeup.

Track 3-1 Chemotherapy
Track 3-2 Radiation Therapy
Track 3-3 Targeted Therapies
Track 3-4 Immunotherapy
Track 3-5 Hormonal Therapy

Related Conferences:

Related Associations:

Related Journals:

Session 4: Precision Medicine

Precision medicine in cancer treatment customizes care according to the unique features of each patient's cancer, including its molecular, genetic, and phenotypic profiles. This method finds certain mutations and biomarkers that direct the choice of targeted medicines, guaranteeing more efficient and individualized treatment regimens. It does this by utilizing genome sequencing and other cutting-edge diagnostics.

Track 4-1 Genomic Profiling
Track 4-2 Tailored Drug Therapies
Track 4-3 Personalized Treatment Plans
Track 4-4 Pharmacogenomics
Track 4-5 Clinical Trials and Data Integration

Related Conferences:

Related Associations:

Related Journals:

Session 5: Cancer Genetics

The study of genetic alterations that propel the onset and spread of cancer is known as cancer genetics. It investigates the roles that somatic changes and hereditary mutations play in the development, expansion, and metastasis of tumours.

Track 5-1 Inherited Cancer Syndromes
Track 5-2 Genetic Risk Assessment
Track 5-3 Gene Editing Technologies
Track 5-4 Epigenetics and Cancer
Track 5-5 Genetic Counselling

Related Conferences:

Related Associations:

Related Journals:

Session 6: Cancer Immunology

Understanding how the immune system interacts with cancer cells and how this affects tumour growth and treatment response is the main goal of cancer immunology. It looks into how immune cells target cancer, how tumours avoid being detected by the immune system, and how immunotherapies like checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are being developed.

Track 6-1 Tumour Antigens
Track 6-2 Immune Checkpoint Inhibitors
Track 6-3 CAR-T Cell Therapy
Track 6-4 Cancer Vaccines
Track 6-5 Tumour-Infiltrating Lymphocytes

Related Conferences:

Related Associations:

Related Journals:

Session 7: Paediatric Oncology

The diagnosis and treatment of cancer in children and adolescents is the focus of paediatric oncology. This topic focuses on the particulars of cancer in younger individuals, such as tumour subtypes, side effects from treatment, and concerns with long-term survivorship.

Track 7-1 Common Paediatric Cancers
Track 7-2 Long-Term Effects of Treatment
Track 7-3 Innovative Therapies
Track 7-4 Supportive Care for Paediatric Patients
Track 7-5 Family and Psychological Support

Related Conferences:

Related Associations:

Related Journals:

Session 8: Hematologic Cancer

The term "hemologic cancer" describes tumours that start in the lymphatic, bone marrow, or blood. This group comprises diseases including multiple myeloma, which affects bone marrow plasma cells, lymphoma, which affects the lymphatic system, and leukaemia, which affects blood and bone marrow.

Track 8-1 Leukaemia
Track 8-2 Lymphomas
Track 8-3 Multiple Myeloma
Track 8-4 Bone Marrow Disorders
Track 8-5 Advances in Hematologic Treatments

Related Conferences:

Related Associations:

Related Journals:

Session 9: Cancer Metastasis

It is the mechanism via which cancer cells metastasize, or spread, from the initial tumour site to other areas of the body. This intricate procedure entails local invasion, penetration by the lymphatic or blood systems, travel to distant locations, and the formation of additional tumours in these areas.

Track 9-1 Mechanisms of Metastasis
Track 9-2 Metastatic Sites and Patterns
Track 9-3 Targeting Metastatic Spread
Track 9-4 Role of the Microenvironment
Track 9-5 Experimental Models and Techniques

Related Conferences:

Related Associations:

Related Journals:

Session 10: Clinical Trials and Research

The goals of clinical trials and research are to improve patient care, find new medicines, and advance current medications. Clinical trials are closely monitored research projects that evaluate novel medications, treatments, or diagnostic techniques for safety, effectiveness, and best practices.

Track 10-1 Designing Clinical Trials
Track 10-2 Phases of Clinical Trials
Track 10-3 Ethical Considerations
Track 10-4 Data Analysis and Interpretation
Track 10-5 Patient Recruitment and Retention

Related Conferences:

Related Associations:

Related Journals:

Session 11: Drug Development

It entails finding, evaluating, and releasing novel cancer treatments onto the market. The first step in the procedure is to discover possible therapeutic targets by doing genetic and biological studies on cancer. Before moving on to clinical trials, which assess a new compound's safety, efficacy, and ideal dosage in humans, preclinical studies investigate the compound's effectiveness and safety in lab animals.

Track 11-1 Preclinical Testing
Track 11-2 Phase I, II, III Trials
Track 11-3 Regulatory Approval
Track 11-4 Post-Marketing Surveillance
Track 11-5 Drug Repurposing

Related Conferences:

Related Associations:

Related Journals:

Session 12: Cancer Prevention

It entails tactics and measures meant to lower the chance of getting cancer. This entails making lifestyle adjustments including eating a balanced diet, exercising frequently, and staying away from recognized carcinogens like smoke and excessive drinking.

Track 12-1 Lifestyle and Environmental Factors
Track 12-2 Vaccination
Track 12-3 Nutritional Interventions
Track 12-4 Public Health Strategies
Track 12-5 Genetic Risk Reduction

Related Conferences:

Related Associations:

Related Journals:

Session 13: Cancer and Aging

Aging and cancer are strongly associated because as people age, their genetic mutation load and cellular repair mechanisms gradually deteriorate, increasing their likelihood of getting cancer. When receiving cancer therapy, older persons may have particular difficulties, such as managing other medical conditions and possible adverse effects from medications.

Track 13-1 Age-Related Cancer Risks
Track 13-2 Geriatric Oncology
Track 13-3 Treatment Considerations in Older Adults
Track 13-4 Survivorship and Aging
Track 13-5 Multidisciplinary Approaches

Related Conferences:

Related Associations:

Related Journals:

Session 14: Molecular and Cellular Techniques

Innovative approaches to investigate and modify cancer cells at the molecular level are used in molecular and cellular strategies for cancer treatment. Important methods consist of:

Track 14-1 CRISPR and Gene Editing
Track 14-2 Single-Cell Sequencing
Track 14-3 Proteomics and Metabolomics
Track 14-4 High-Throughput Screening
Track 14-5 Bioinformatics Tools

Related Conferences:

Related Associations:

Related Journals:

Session 15: Patient-Centred Care

It places a strong emphasis on adjusting care and assistance to each patient's unique requirements and preferences. Personalized Treatment Plans, all-encompassing support, and active engagement are all part of this strategy.

Track 15-1 Quality of Life Assessments
Track 15-2 Palliative and Supportive Care
Track 15-3 Patient-Physician Communication
Track 15-4 Psychosocial Support
Track 15-5 Patient Advocacy and Rights

Related Conferences:

Related Associations:

Related Journals:

Session 16: Cancer Epidemiology

The distribution causes, and trends of cancer within populations are studied by cancer epidemiology. It includes risk factor identification, surveillance, prevention, and incidence and prevalence analysis.

Track 16-1 Cancer Incidence and Prevalence
Track 16-2 Risk Factors and Correlations
Track 16-3 Geographical Variations
Track 16-4 Surveillance and Monitoring
Track 16-5 Data Collection and Analysis

Related Conferences:

Related Associations:

Related Journals:

Session 17: Surgical Oncology

Cancerous growths related to skin, breast, liver, pancreatic, colon, or other cancers can be successfully removed with surgery. Surgical oncologists may remove adjacent lymph nodes, remove healthy tissue around malignant tumours, or remove all or part of the tumours while treating cancer.

Track 17-1 Minimally Invasive Surgery
Track 17-2 Robotic-Assisted Surgery
Track 17-3 Oncological Resections
Track 17-4 Reconstructive Surgery
Track 17-5 Surgical Innovations and Outcomes

Related Conferences:

Related Associations:

Related Journals:

Session 18: Radiology in Oncology

Radiation oncology or radiation therapies are other names for therapeutic radiology. It is the use of radiation therapy to treat cancer and other illnesses. The area of medicine dedicated to the diagnosis and treatment of cancer is called oncology. Many types of radiation are used to kill cancer cells by stopping them from proliferating.

Track 18-1 Advanced Imaging Techniques
Track 18-2 Interventional Radiology
Track 18-3 Radiomics and Imaging Biomarkers
Track 18-4 Radiotherapy Planning
Track 18-5 Patient Safety and Quality Assurance

Related Conferences:

Related Associations:

Related Journals:

Session 19: Cancer Pharmacology

It includes research on the fundamental mechanisms of signal transduction linked to cell division and apoptosis, the modes of action of anti-neoplastic medications, the creation and discovery of new medications, the fundamental mechanisms of DNA damage tolerance and repair, and the creation of innovative gene therapy techniques.

Track 19-1 Mechanisms of Drug Action
Track 19-2 Pharmacokinetics and Pharmacodynamics
Track 19-3 Toxicity and Side Effects
Track 19-4 Drug Interactions
Track 19-5 Novel Drug Classes

Related Conferences:

Related Associations:

Related Journals:

Session 20: Cancer and Nutrition

There is a strong correlation between nutrition and cancer because dietary decisions can affect cancer risk, treatment effectiveness, and general health both before and after cancer therapy. Important elements consist of:

Track 20-1 Nutritional Needs During Treatment
Track 20-2 Impact of Diet on Cancer Progression
Track 20-3 Supplements and Complementary Therapies
Track 20-4 Nutritional Counselling
Track 20-5 Diet and Prevention

Related Conferences:

Related Associations:

Related Journals:

Session 21: Cancer Survivorship

The focus of cancer survivorship is on the all-encompassing care and assistance required for those who have finished their cancer treatment. It entails managing long-term side effects, attending to both physical and emotional needs, and continuing to watch for recurrence. Plans for survivorship care are created to direct follow-up treatment and encourage a healthy lifestyle.

Track 21-1 Long-Term Consequences of Cancer Therapy
Track 21-2 Rehabilitation and Recovery
Track 21-3 Survivorship Care Plans
Track 21-4 Mental Health and Wellness
Track 21-5 Community Resources and Support

Related Conferences:

Related Associations:

Related Journals:

Session 22: Integrative Oncology

Integrative oncology seeks to enhance patient care by combining conventional cancer treatments with complementary therapies. This approach blends standard medical treatments with practices such as acupuncture, meditation, and nutritional counselling, addressing the whole person—body, mind, and spirit.

Track 22-1 Complementary Therapies
Track 22-2 Mind-Body Practices
Track 22-3 Combining Conventional and Alternative Medicine
Track 22-4 Patient Preferences and Efficacy
Track 22-5 Safety and Regulation

Related Conferences:

Related Associations:

Related Journals:

Session 23: Health Disparities in Cancer

The term "health disparities in cancer" describes the uneven incidence and prognosis of the disease in various populations, which are frequently impacted by racial or ethnic background, socioeconomic level, and place of residence. Variations in cancer incidence, treatment results, and access to care can result from these inequities.

Track 23-1 Access to Care
Track 23-2 Socioeconomic Factors
Track 23-3 Racial and Ethnic Disparities
Track 23-4 Geographic Variations
Track 23-5 Strategies for Equity

Related Conferences:

Related Associations:

Related Journals:

Session 24: Global Oncology

Global oncology focuses on the differences and difficulties that exist between various geographical areas when addressing cancer prevention, treatment, and research on a worldwide level. It entails working together internationally to exchange information, materials, and cancer prevention tactics.

Track 24-1 Cancer Burden Worldwide
Track 24-2 International Collaborative Research
Track 24-3 Healthcare Infrastructure
Track 24-4 Global Health Initiatives
Track 24-5 Cultural Considerations in Treatment

Related Conferences:

Related Associations:

Related Journals:

Session 25: Future Directions in Oncology

Oncology's future paths promise to transform cancer therapy via technological and personalized medical breakthroughs. Among the innovations are the integration of machine learning and artificial intelligence for predictive analytics, early detection, and optimal treatment regimens.

Track 25-1 Emerging Technologies
Track 25-2 Innovations in Treatment
Track 25-3 Next-Generation Sequencing
Track 25-4 Artificial Intelligence and Machine Learning
Track 25-5 Future Research Trends

Related Conferences:

Related Associations:

Related Journals:

About

The Cancer Research and Treatment Conference, set to take place on October 17-18, 2024, in the enchanting city of London, UK, warmly invite a diverse audience to participate. We are excited to welcome R&D companies, Ph.D. candidates, physicians, healthcare organizations, advertising agencies, researchers, medical colleges, faculties, associations, diagnostic centres, pharmaceutical companies, product development and marketing professionals, healthcare industries, and medical device manufacturers from around the world.

We encourage you to be part of this prestigious event to explore and discuss the latest developments, trends, challenges, and solutions in cancer research and treatment. Hosted by Pulsus, this international conference aims to offer a distinguished platform for knowledge sharing, ground breaking discoveries, and the promotion of technical advancements in the field.

With the theme of “Global Cancer Disparities and Health Equity” in Cancer Research and Treatment, Cancer 2024 seeks to advance treatment strategies through the exchange of experiences and expertise. By bringing together leading speakers, scientists, and researchers globally, the conference fosters an environment for innovative ideas and unique concepts in cancer research and treatment.

The event will feature comprehensive lectures, symposia, workshops, scientific sessions, and poster presentations, creating an ideal setting for in-depth discussions and advancements in cancer care. We emphasize maintaining professional integrity while promoting progress with dignity and excellence.

Cancer 2024 Conference provides a valuable opportunity for researchers to expand their work and contribute to the field's growth. We eagerly anticipate your contributions and dedication to making this event a tremendous success.

Join us at the 3rd International Conference on Cancer Research and Treatment and become part of a dynamic community committed to pushing the boundaries of knowledge in cancer. We look forward to your participation and contributions to this exceptional event.

Awards:

Researchers who have made significant contributions to Cancer 2024 Conference will be recognised with prestigious awards at Cancer 2024.

List of awards presented for the attendees at Cancer 2024

Young Scientist Award
Best Speaker Award.
Best Poster Award.
Best Keynote Speaker Award
Best Organizing Committee Member Award

Market Analysis

In 2023, the global market for oncology drugs was valued at USD 201.75 billion. It is expected to grow from USD 220.80 billion in 2024 to USD 518.25 billion by 2032, reflecting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2032. This growth encompasses a broad spectrum of medications, including targeted therapies, chemotherapy agents, immunotherapies, and hormone therapies used in cancer treatment. Key drivers of market expansion include the increasing incidence of various cancers, frequent new drug introductions and approvals, and escalating research investments by pharmaceutical companies.

Regional Insights

In 2023, North America led the oncology drugs market with a valuation of USD 92.65 billion. This dominance is fuelled by the rising cancer incidence in the U.S. and frequent new product launches in the region. According to data from the American Association of Cancer Research published in 2022, the number of annual cancer diagnoses in the U.S. is expected to approach 2.3 million by 2040.

Europe is projected to hold the second-largest market share, driven by high-growth countries such as the U.K., Germany, France, Italy, and Spain, where increasing cancer rates are contributing to market growth.

The Asia-Pacific region is anticipated to experience rapid growth due to rising cancer awareness, increased cancer prevalence, and higher healthcare spending.

Significant Market Trends

A significant factor contributing to the expansion of the oncology drugs market is the growing application of immunotherapy. This innovative treatment harnesses the body's immune system to target and combat cancer cells. Immunotherapy has demonstrated effectiveness, particularly in advanced stages of cancer, though its suitability varies depending on the tumour type and patient condition. It is applicable to a range of cancers, including lung, kidney, bladder, melanoma, cervical, and lymphoma.

Research conducted in India has highlighted the potential benefits of using very low doses of the immunotherapy drug nivolumab (Opdivo) for patients with advanced head and neck cancer. Remarkably, these low doses, which are only 6% of the standard amount used in the U.S. and Europe, have shown to extend patient survival and could be more cost-effective.

Additionally, the integration of low-dose nivolumab with conventional treatments in India has been explored in clinical studies. As the incidence of tumours rises in India, there is a growing focus on developing advanced technologies for better diagnosis, treatment, and management of cancer, further propelling market growth during the forecast period.

Visa Support

While securing a visa is ultimately managed through your home country's official channels, we recognize the importance of assisting you with this process to ensure your participation in our conference. To facilitate your visa application, we offer a comprehensive support package tailored to your needs.

By registering as a speaker or delegate for the Cancer 2024, you can request the following essential documents:

Official Invitation Letter: This formal letter verifies your role in the conference, detailing the event's purpose, dates, and location. It serves as official proof of your travel plans and involvement in this significant academic and educational event.
Visa Support Letter: This document is crafted to support your visa application by explaining the importance of your participation. It highlights your contributions, such as any presentations or workshops, thereby underscoring the educational value and legitimacy of your visit.
Payment Confirmation Receipt: This receipt confirms your registration and payment, providing solid evidence of your commitment to attending the conference.

To obtain your personalized visa support package, please register as a speaker or delegate and send your passport number to our dedicated email addresses:cancer@alliedgathering.com or cancer@pulsusgather.com